Glottis squamous cell carcinoma
MONDO:0004080A squamous cell carcinoma of the larynx that arises from the glottic area. It may remain localized for a long period then in late disease stage, it may spread to the opposite true vocal cord, supraglottic and subglottic areas, and the soft tissues of the neck. Hoarseness is the presenting symptom.
Also known as: epidermoid carcinoma of glottis, epidermoid carcinoma of the glottis, glottic epidermoid carcinoma, glottic squamous cell carcinoma, glottis epidermoid carcinoma, glottis squamous cell carcinoma, squamous cell carcinoma of glottis, squamous cell carcinoma of the glottis
2855 clinical trials for this condition and its sub-types, 5 tagged with Glottis squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Glottis squamous cell carcinoma
-
Glottis verrucous carcinoma 0 trials
-
Can a radiation boost keep early Voice-Box cancer from returning?
Disease control Recruiting nowThis trial is testing whether giving radiotherapy after surgery can lower the risk of cancer returning in people with early-stage glottic (voice box) cancer that has spread to the anterior commissure. Participants will receive intensity modulated radiotherapy (IMRT) after their s…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can targeted radiation outperform surgery for a tough throat cancer?
Disease control Recruiting nowThis trial investigates whether intensity-modulated radiotherapy (IMRT) can improve local control in patients with early-stage glottic (voice box) cancer that is poorly differentiated—a type that tends to recur more often after surgery. Adults with T1-T2N0M0 glottic squamous cell…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New radiation schedule could cut treatment time for throat cancer patients
Disease control Recruiting nowThis phase II trial compares a new, shorter radiation schedule (LT-SABR, given over 1-2 weeks) to standard radiation (over 5-6 weeks) for early-stage laryngeal cancer. The goal is to see if the shorter schedule causes fewer severe side effects in the first 3 months. About 67 adul…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Robotic surgery plus daily swallowing therapy aims to keep head and neck cancer patients eating and speaking normally
Symptom relief Recruiting nowThis study tests whether a personalized 12-week speech, swallowing, and voice rehabilitation program can help preserve swallowing function in head and neck cancer patients after minimally invasive robotic surgery. About 53 participants will be enrolled, including those having sur…
Sponsor: Christian Simon • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC